Charts Zura Bio Limited

Equities

End-of-day quote Nasdaq Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
4.46 ^USD	-8.61%		-15.05%	-4.50%

06-03	Zura Bio Limited to Present Data Exploring the Expanded Potential of Tibulizumab Into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024	CI
05-23	Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing	MT

ProRealTime Chart